Cravens & CO Advisors, LLC GSK PLC Transaction History

Cravens & CO Advisors, LLC

  • $134 Billion
  • Q2 2025
Number of Shares
7,759
Previous 7,589 2.24%
Holding current value
$298 Million
Previous $294 Million 1.34%
% of portfolio
0.22%
Previous 0.23%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
N/A
170 Added 2.24%
7,759 $298 Million
Q1 2025

May 14, 2025
BUY
N/A
7,589 New
7,589 $294 Million
Q3 2024

Nov 13, 2024
SELL
N/A
-881 Reduced 10.56%
7,459 $305 Million
Q2 2024

Aug 01, 2024
SELL
N/A
-197 Reduced 2.31%
8,340 $321 Million
Q1 2024

Apr 02, 2024
SELL
N/A
-382 Reduced 4.28%
8,537 $366 Million
Q4 2023

Feb 09, 2024
SELL
N/A
-315 Reduced 3.41%
8,919 $331 Million
Q3 2023

Nov 15, 2023
SELL
N/A
-99 Reduced 1.06%
9,234 $335 Million
Q2 2023

Jul 27, 2023
SELL
N/A
-76 Reduced 0.81%
9,333 $333 Million
Q1 2023

May 26, 2023
BUY
N/A
3 Added 0.03%
9,409 $335 Million
Q4 2022

Feb 24, 2023
BUY
N/A
9,406 New
9,406 $331 Million
Track This Portfolio

Track Cravens & CO Advisors, LLC Portfolio

Follow Cravens & CO Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cravens & CO Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cravens & CO Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email